CMS delays end of third-party remote monitoring payments until 2029

CMS has pushed the end of Medicare payment for remote patient monitoring (RPM) furnished by third-party vendors to Jan. 1, 2029, a two-year reprieve from the original Jan. 1, 2027 start date, under the finalized 2027 Medicare Physician Fee Schedule, Healthcare Dive reports. The agency cited HHS Office of Inspector General reports that outsourcing can leave the billing provider without enough oversight of the care delivered.

The scope is narrower than the headline. Daniel Tashnek, CEO of Prevounce, wrote that the staffing restriction covers only clinical time codes CPT 99457, 99458 and 99470, per Physicians Practice. Devices, software, data hosting and technical assistance can still come from vendors, and contracted clinical staff remain allowed in 2027 and 2028. Other changes start Jan. 1: remote therapeutic monitoring is limited to established patients, a separately reportable initiating visit is required when monitoring begins, and Tashnek wrote that device codes take the biggest cut in 2027 while treatment management codes held steady.

The broader pay picture is tighter. The conversion factor is $32.95 for clinicians in qualifying advanced alternative payment models, a 1.83% cut, and $32.63 for everyone else, a 2.31% cut, deeper than the 1.19% and 1.68% CMS proposed in July, Medical Economics reports. AMGA said the cuts follow expiration of a 2.5% increase Congress enacted for 2026, and both ACP and AMGA are asking for a permanent fix rather than another one-year patch. CMS also finalized a 20% reduction for modifier 25 services, and 10 new speech-language pathology codes replace a single code on Jan. 1, per the same report.

What the evidence shows: the 2029 date, the rates and the Jan. 1 changes are in the final rule. What it does not show: whether Congress acts on the conversion factor, or what the staffing rule will look like by 2029. Tashnek said he expects it "to look different by 2029," and ATA Action plans to use the next two rulemaking cycles to press for program-integrity safeguards, per Healthcare Dive.

The move: finance should model 2027 revenue at the new conversion factor with lower device payments and no congressional relief assumed. Compliance and technology leaders should review RPM contracts, separating clinical time from technology services and documenting physician oversight, the gap OIG flagged. Nursing leaders should use the two years to decide whether to build employed monitoring teams and set up initiating-visit workflows now, so patients with chronic conditions keep continuous monitoring whichever way the 2029 rule lands.

You are a revenue cycle and finance advisor to the executive team of [your organization], a [type of medical group or health system].

Context, from the finalized 2027 Medicare Physician Fee Schedule as reported by Healthcare Dive, Physicians Practice and Medical Economics: CMS pushed the end of Medicare payment for remote patient monitoring furnished by third-party vendors to Jan. 1, 2029, from the original Jan. 1, 2027 date, citing HHS Office of Inspector General concerns about oversight. Per Physicians Practice, the staffing restriction covers only CPT 99457, 99458 and 99470; devices, software, data hosting and technical assistance can still come from vendors, and contracted clinical staff remain allowed in 2027 and 2028. Device codes take the biggest cut in 2027. Per Medical Economics, the conversion factor is $32.95 for qualifying advanced alternative payment model clinicians, a 1.83% cut, and $32.63 for everyone else, a 2.31% cut, following expiration of a 2.5% increase for 2026. CMS also finalized a 20% reduction for modifier 25 services, and 10 new speech-language pathology codes replace one code on Jan. 1. ACP and AMGA want a permanent congressional fix; whether Congress acts is unknown.

Task: review our third-party remote monitoring contracts and model 2027 revenue with the payment delay and the pay cuts included, assuming no congressional relief.

Output: a one-page memo for the executive team with these sections: Summary, 2027 Revenue Model, RPM Contract Review (clinical time versus technology services), Risks and Unknowns, Decisions Needed.

My inputs: [your 2026 Medicare physician fee schedule revenue], [your annual Medicare RPM revenue by code], [the number of RPM vendor contracts and their renewal dates], [your share of clinicians in qualifying advanced alternative payment models], [your annual modifier 25 volume].

Use only the facts above and the inputs I fill in. Cite Healthcare Dive, Physicians Practice and Medical Economics by name. Flag anything uncertain or that must be verified against the final rule or our contracts. Include no patient data. Nothing here is medical advice. Label the memo as a draft for the team to check.